{
    "contraindications": [
        {
            "id": "contra_001",
            "drug": "metformin",
            "condition": "renal_impairment",
            "severity": "high",
            "rationale": "Metformin is renally cleared. Impaired renal function increases lactic acidosis risk",
            "clinical_criteria": "eGFR < 30 mL/min/1.73m² (absolute), eGFR 30-45 (relative)",
            "penalty": -8,
            "management": "Contraindicated if eGFR <30, use caution 30-45, monitor renal function",
            "evidence_level": "High",
            "source": "FDA Black Box Warning, ADA Guidelines"
        },
        {
            "id": "contra_002",
            "drug": "ibuprofen",
            "condition": "heart_failure",
            "severity": "medium",
            "rationale": "NSAIDs cause fluid retention and worsen heart failure, increase hospitalization risk",
            "clinical_criteria": "NYHA Class III-IV heart failure",
            "penalty": -5,
            "management": "Avoid NSAIDs, use acetaminophen or topical alternatives",
            "evidence_level": "High",
            "source": "ACC/AHA Heart Failure Guidelines, FDA"
        },
        {
            "id": "contra_003",
            "drug": "aspirin",
            "condition": "renal_impairment",
            "severity": "medium",
            "rationale": "High-dose aspirin may worsen renal function via prostaglandin inhibition",
            "clinical_criteria": "Severe CKD (Stage 4-5), eGFR <30",
            "penalty": -5,
            "management": "Use low-dose aspirin cautiously, avoid high doses",
            "evidence_level": "Medium",
            "source": "KDIGO Guidelines, Clinical Pharmacology"
        },
        {
            "id": "contra_004",
            "drug": "lisinopril",
            "condition": "renal_impairment",
            "severity": "medium",
            "rationale": "ACE inhibitors may cause hyperkalemia and acute renal decline in CKD",
            "clinical_criteria": "eGFR < 30, bilateral renal artery stenosis",
            "penalty": -5,
            "management": "Dose reduction required, monitor K+ and creatinine closely",
            "evidence_level": "Medium-High",
            "source": "KDIGO, FDA Label"
        },
        {
            "id": "contra_005",
            "drug": "warfarin",
            "condition": "atrial_fibrillation",
            "severity": "beneficial",
            "rationale": "Warfarin is INDICATED for stroke prevention in AF (this is NOT a contraindication)",
            "clinical_criteria": "CHA2DS2-VASc ≥2 for males, ≥3 for females",
            "penalty": 0,
            "management": "Standard anticoagulation with INR monitoring",
            "evidence_level": "High",
            "source": "ESC/AHA AF Guidelines"
        },
        {
            "id": "contra_006",
            "drug": "atorvastatin",
            "condition": "diabetes",
            "severity": "caution",
            "rationale": "Statins slightly increase diabetes risk but benefits outweigh risks in CVD prevention",
            "clinical_criteria": "Pre-existing diabetes or high risk",
            "penalty": 0,
            "management": "Monitor glucose, but do not withhold statin",
            "evidence_level": "Medium",
            "source": "ACC/AHA Cholesterol Guidelines"
        }
    ],
    "metadata": {
        "version": "1.0.0",
        "last_updated": "2026-01-02",
        "total_contraindications": 6,
        "severity_distribution": {
            "high": 1,
            "medium": 3,
            "beneficial": 1,
            "caution": 1
        },
        "sources": [
            "FDA Labels",
            "Clinical Practice Guidelines",
            "KDIGO",
            "ACC/AHA"
        ],
        "curator": "Herald Michain Samuel Theo Ginting",
        "note": "Includes both true contraindications and clinically important drug-condition interactions"
    }
}